TY  - JOUR
AU  - Grandal, Marta
AU  - Pernas, Berta
AU  - Tabernilla, Andres
AU  - Mariño, Ana
AU  - Alvarez, Hortensia
AU  - Valcarce, Nieves
AU  - Mena, Alvaro
AU  - Castro-Iglesias, Angeles
AU  - Perez, Ana B
AU  - Delgado, Manuel
AU  - Poveda, Eva
PY  - 2018
DO  - 10.1002/jmv.25048
UR  - http://hdl.handle.net/10668/12111
T2  - Journal of medical virology
AB  - The presence of resistance-associated substitutions (RASs) at NS5A region might compromise the efficacy of Direct Acting Antiviral agents (DAAs). HCV resistance at NS5A region is mainly focused on patients with hepatitis C virus (HCV) genotypes 1a...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - HCV-infection
KW  - NS5A
KW  - RASs
KW  - genotype 1a
KW  - genotype 3
KW  - Adult
KW  - Amino Acid Substitution
KW  - Antiviral Agents
KW  - Drug Resistance, Viral
KW  - Follow-Up Studies
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutant Proteins
KW  - Mutation, Missense
KW  - Prevalence
KW  - Ribavirin
KW  - Sequence Analysis, DNA
KW  - Viral Nonstructural Proteins
TI  - Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies.
TY  - research article
VL  - 90
ER  -